Department of Health(DOH)

Browse over 23955 from this government agency

Go Back

REQUEST
SUBMITTED

You have submitted an FOI request

Date: Oct. 20, 2022, 9:04 p.m.

PROCESSING
REQUEST

Your request is already in review

Date: 2022-10-21 10:03:43.000000

REQUEST
SUCCESSFUL

Your request was successful

Date: 2022-11-04 14:39:36.000000

4

RATE YOUR
REQUEST

How was your request?

Remdesivir for Covid-19 Part 1

Published by Department of Health(DOH) on Oct. 20, 2022.
Requested from DOH by R. Cuartero at 09:04 PM on Oct. 20, 2022.
Purpose: Data Management
Date of Coverage: 01/01/2020 - 10/20/2022
Tracking no: #DOH-720408872735

R.CUARTERO Oct. 20, 2022, 9:04 p.m.

Greetings. 1. Please provide us DOH guidelines to Philippines healthcare system on the use of Remdesivir. 2. Please provide us with data/studies on the efficacy of Remdesivir in treating Covid-19 patients. Thank you.

F.RECEIVING OFFICER Oct. 21, 2022, 10:03 a.m.

October 21, 2022 Dear Ryan, Thank you for your request dated Oct 20, 2022 under Executive Order No. 2 (s. 2016) on Freedom of Information in the Executive Branch, for Remdesivir for Covid-19 Part 1. We received your request on Oct 20, 2022 and will respond on or before Nov 10, 2022 09:04:06 PM, in accordance with the Executive Order's implementing rules and regulations. Should you have any questions regarding your request, kindly contact me using the reply function on the eFOI portal at https://2018midyear08242018-dot-efoi-ph.appspot.com/requests/aglzfmVmb2ktcGhyHQsSB0NvbnRlbnQiEERPSC03MjA0MDg4NzI3MzUM, for request with ticket number #DOH-720408872735. Thank you. Respectfully, FOI Receiving Officer FOI Officer

F.MAKER Oct. 24, 2022, 3 p.m.

Dear Ryan Cuartero Please be informed that your request has been endorsed to the Health Technology Assessment Division (HTAD) for action. Kindly wait for their response, thank you

F.MAKER Nov. 4, 2022, 2:39 p.m.

November 4, 2022 Dear Ryan Cuartero, Greetings! Thank you for your request dated Oct 20, 2022 09:04:06 PM under Executive Order No. 2 (s. 2016) on Freedom of Information in the Executive Branch. Your Request You asked for Remdesivir for Covid-19 Part 1. Response to Request Your FOI request is approved. Below are the responses to your request 1. Please refer to the attached Department Circular No. 2022-0002 with the subject “Advisory on COVID-19 Protocols for Quarantine and Isolation” 2. Based on the 2021 LCPG Review (Appendix 3. Figures 2-11) at https://www.psmid.org/wp-content/uploads/2021/03/TREATMENT_Remdesivir-v1_March-16-2021.pdf, in terms of efficacy outcomes, the results of the following clinical trials were pooled: ● Spinner et al., 2020 - https://jamanetwork.com/journals/jama/fullarticle/2769871 ● Beigel et al., 2020 - https://www.nejm.org/doi/full/10.1056/nejmoa2007764 ● Wang et al., 2020 - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054408/ ● WHO solidarity consortium - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727327/ Thank you Your right to request a review If you are unhappy with this response to your FOI request, you may ask us to carry out an internal review of the response by writing to DOH Central Appeals and Review Committee, at [email protected]. Your review request should explain why you are dissatisfied with this response, and should be made within 15 calendar days from the date when you received this letter. We will complete the review and tell you the result within 30 calendar days from the date when we receive your review request. If you are not satisfied with the result of the review, you then have the right to appeal to the Office of the President under Administrative Order No. 22 (s. 2011). Thank you. Respectfully, FOI Decision Maker FOI Receiving Officer

Attachments:

dc2022-0002.pdf - FOI Decision Maker - [email protected]

Is this request offensive?

Requests for personal information and vexatious requests are not considered valid requests for Official Information.

If you believe this request is not suitable, you can report it for attention by the site administrators.